UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 68

Sortiert nach

Immunoglobulin domain crossover as a generic approach for the production of bispecific IgG antibodies

Proceedings of the National Academy of Sciences - PNAS, 2011-07, Vol.108 (27), p.11187-11192

2011

Link zum Volltext

Verfügbarkeit prüfen

Progress in overcoming the chain association issue in bispecific heterodimeric IgG antibodies

mAbs, 2012-11, Vol.4 (6), p.653-663

2012

Link zum Volltext

Verfügbarkeit prüfen

The use of CrossMAb technology for the generation of bi- and multispecific antibodies

mAbs, 2016-08, Vol.8 (6), p.1010-1020

2016

Link zum Volltext

Verfügbarkeit prüfen

A Human Neutralizing Antibody Specific to Ang-2 Inhibits Ocular Angiogenesis

Microcirculation (New York, N.Y. 1994), 2011-10, Vol.18 (7), p.598-607

2011

Link zum Volltext

Verfügbarkeit prüfen

Targeting key angiogenic pathways with a bispecific CrossMAb optimized for neovascular eye diseases

EMBO molecular medicine, 2017-07, Vol.9 (7), p.985-985

2017

Link zum Volltext

Verfügbarkeit prüfen

Targeting key angiogenic pathways with a bispecific CrossMAb optimized for neovascular eye diseases

EMBO molecular medicine, 2016-11, Vol.8 (11), p.1265-1288

2016

Link zum Volltext

Verfügbarkeit prüfen

Nicalin and its binding partner Nomo are novel Nodal signaling antagonists

The EMBO journal, 2004-08, Vol.23 (15), p.3041-3050

2004

Link zum Volltext

Verfügbarkeit prüfen

A novel angiopoietin-2 selective fully human antibody with potent anti-tumoral and anti-angiogenic efficacy and superior side effect profile compared to Pan-Angiopoietin-1/-2 inhibitors

PloS one, 2013-02, Vol.8 (2), p.e54923-e54923

2013

Link zum Volltext

Verfügbarkeit prüfen

Heavy and light chain pairing of bivalent quadroma and knobs-into-holes antibodies analyzed by UHR-ESI-QTOF mass spectrometry

mAbs, 2016-01, Vol.8 (1), p.49-55

2016

Link zum Volltext

Verfügbarkeit prüfen

Targeting key angiogenic pathways with a bispecific CrossMAb optimized for neovascular eye diseases

EMBO molecular medicine, 2019-05, Vol.11 (5), p.n/a

2019

Link zum Volltext

Verfügbarkeit prüfen

A combination of different mass spectroscopic techniques for the analysis of dynamic changes of histone modifications

Proteomics (Weinheim), 2004-05, Vol.4 (5), p.1382-1396

2004

Link zum Volltext

Verfügbarkeit prüfen

Differential Effects of Parkinson's Disease-associated Mutations on Stability and Folding of DJ-1

The Journal of biological chemistry, 2004-02, Vol.279 (8), p.6943-6951

2004

Link zum Volltext

Verfügbarkeit prüfen

The N-Terminus of Drosophila SU(VAR)3−9 Mediates Dimerization and Regulates Its Methyltransferase Activity

Biochemistry (Easton), 2004-03, Vol.43 (12), p.3740-3749

2004

Link zum Volltext

Verfügbarkeit prüfen

Analysis of the major proteins secreted by the human opportunistic pathogen Aspergillus fumigatus under in vitro conditions

Medical mycology (Oxford), 2005-11, Vol.43 (7), p.623-630

2005

Link zum Volltext

Verfügbarkeit prüfen

The Use of Mass Spectrometry for the Analysis of Histone Modifications

Methods in Enzymology, 2003, Vol.377, p.111-130

2003

Link zum Volltext

Verfügbarkeit prüfen

Targeting key angiogenic pathways with a bispecific Cross MA b optimized for neovascular eye diseases

EMBO molecular medicine, 2019-05, Vol.11 (5)

2019

Link zum Volltext

Verfügbarkeit prüfen

Abstract 3629: Engineering a novel asymmetric head-to-tail 2+1 T-cell bispecific (2+1 TCB) IgG antibody platform with superior T-cell killing compared to 1+1 asymmetric TCBs

Cancer research (Chicago, Ill.), 2017-07, Vol.77 (13_Supplement), p.3629-3629

2017

Link zum Volltext

Verfügbarkeit prüfen

Targeting key angiogenic pathways with a bispecific Cross MA b optimized for neovascular eye diseases

EMBO molecular medicine, 2017-07, Vol.9 (7), p.985-985

2017

Link zum Volltext

Verfügbarkeit prüfen

Towards a two-dimensional proteome map ofMycoplasma pneumoniae

Electrophoresis, 2000-11, Vol.21 (17), p.3765-3780

2000

Link zum Volltext

Verfügbarkeit prüfen

Targeting key angiogenic pathways with a bispecific Cross MA b optimized for neovascular eye diseases

EMBO molecular medicine, 2016-11, Vol.8 (11), p.1265-1288

2016

Link zum Volltext

Verfügbarkeit prüfen

The use of mass spectrometry for the analysis of histone modifications

Methods in enzymology, 2004, Vol.377, p.111-130

2004

Link zum Volltext

Verfügbarkeit prüfen

Towards a two-dimensional proteome map of Mycoplasma pneumoniae

Electrophoresis, 2000-11, Vol.21 (17), p.3765-3780

2000

Link zum Volltext

Verfügbarkeit prüfen

Developability Assessment During the Selection of Novel Therapeutic Antibodies

Journal of pharmaceutical sciences, 2015-06, Vol.104 (6), p.1885-1898

2015

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 68

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(60)
Mit Volltextzugriff
(54)

Publikationsform

Sprache

Englisch
(66)
Japanisch
(10)
Deutsch
(3)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Immunoglobulin domain crossover as a generic approach for the production of bispecific IgG antibodies

Progress in overcoming the chain association issue in bispecific heterodimeric IgG antibodies

The use of CrossMAb technology for the generation of bi- and multispecific antibodies

A Human Neutralizing Antibody Specific to Ang-2 Inhibits Ocular Angiogenesis

Targeting key angiogenic pathways with a bispecific CrossMAb optimized for neovascular eye diseases

Targeting key angiogenic pathways with a bispecific CrossMAb optimized for neovascular eye diseases

Nicalin and its binding partner Nomo are novel Nodal signaling antagonists

A novel angiopoietin-2 selective fully human antibody with potent anti-tumoral and anti-angiogenic efficacy and superior side effect profile compared to Pan-Angiopoietin-1/-2 inhibitors

Heavy and light chain pairing of bivalent quadroma and knobs-into-holes antibodies analyzed by UHR-ESI-QTOF mass spectrometry

DuoMab: a novel CrossMab-based IgG-derived antibody format for enhanced antibody-dependent cell-mediated cytotoxicity

Targeting key angiogenic pathways with a bispecific CrossMAb optimized for neovascular eye diseases

A combination of different mass spectroscopic techniques for the analysis of dynamic changes of histone modifications

Differential Effects of Parkinson's Disease-associated Mutations on Stability and Folding of DJ-1

The N-Terminus of Drosophila SU(VAR)3−9 Mediates Dimerization and Regulates Its Methyltransferase Activity

Analysis of the major proteins secreted by the human opportunistic pathogen Aspergillus fumigatus under in vitro conditions

The Use of Mass Spectrometry for the Analysis of Histone Modifications

DuoMab: a novel CrossMab-based IgG-derived antibody format for enhanced antibody-dependent cell-mediated cytotoxicity

Targeting key angiogenic pathways with a bispecific Cross MA b optimized for neovascular eye diseases

Abstract 3629: Engineering a novel asymmetric head-to-tail 2+1 T-cell bispecific (2+1 TCB) IgG antibody platform with superior T-cell killing compared to 1+1 asymmetric TCBs

Targeting key angiogenic pathways with a bispecific Cross MA b optimized for neovascular eye diseases

Towards a two-dimensional proteome map ofMycoplasma pneumoniae

Targeting key angiogenic pathways with a bispecific Cross MA b optimized for neovascular eye diseases

The use of mass spectrometry for the analysis of histone modifications

Towards a two-dimensional proteome map of Mycoplasma pneumoniae

Developability Assessment During the Selection of Novel Therapeutic Antibodies

Suchergebnisse filtern